Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2022-09-26 00:00:00 ET · period of report 2022-09-22 · accession 0001628280-22-025508 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-26 | 2022-09-22 | CLOV | Edwards Carladenise Armbrister | Dir | A - Grant | $0.00 | +20.3K | 29.1K | +230% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-09-22 | A | A | 20,271 | $0.00 | 29,076 | D | — | — | (F1) Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSU"). One hundred percent of the RSUs will vest on the first anniversary of the Date of Grant, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such date. |